Apontis Pharma Deutschland Gmbh & Co. Kg

Apontis Pharma Deutschland Gmbh & Co. Kg company information, Employees & Contact Information

APONTIS PHARMA (previously UCB Innere Medizin) is a German pharmaceutical company and currently active on the national market. We deliberately chose our name (lat. Pons = "the bridge"). We build bridges and see ourselves as mediators, supporters and donors of connections. We network doctors, patients, partners and health policy institutions. APONTIS PHARMA develops, markets and distributes a broad portfolio of single pills and other medicines, with a particular focus on cardiovascular diseases.With a steadily growing range of Single Pill combinations for the treatment of cardiovascular diseases such as hypertension, lipid metabolism disorders and secondary prevention (treatments after the first heart attack or stroke) since 2013, we have created a good starting point for further growth and the vision of establishing the Single Pill therapy concept as the gold standard in the care of cardiovascular patients in the medium term. Single Pills combine two to three off-patent active ingredients in a combination preparation that is taken once a day. We have made a name for ourselves through our own product developments and the in-licensing of medicines that stand out as "best in class" due to their excellent study situation. We enter into strategic partnerships with companies by co-financing the research and development of these groundbreaking medicines and by communicating the high patient benefit to doctors through our sales force. In addition to our medicines, we take a holistic view of doctors' practices and patients. After all, medicines can only ever be part of the therapy. Our activities are therefore not only geared towards medical-scientific training of doctors, but go beyond that.

Company Details

Employees
96
Founded
-
Address
Rolf-Schwarz-Schütte Platz 1, Monheim Am Rhein,north Rhine-Westphalia 40789,germany
Phone
+49 2173 48 4949
Email
in****@****arma.de
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Monheim am Rhein, North Rhine-Westphalia
Looking for a particular Apontis Pharma Deutschland Gmbh & Co. Kg employee's phone or email?

Apontis Pharma Deutschland Gmbh & Co. Kg Questions

News

APONTIS PHARMA: Changes in the Management Board - Yahoo Finance

APONTIS PHARMA: Changes in the Management Board Yahoo Finance

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG - PR Newswire

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG PR Newswire

Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer - PR Newswire

Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer PR Newswire

Germany: Zentiva secures approximately 85.27% of Apontis Pharma voting rights in public purchase offer - Investors in Healthcare

Germany: Zentiva secures approximately 85.27% of Apontis Pharma voting rights in public purchase offer Investors in Healthcare

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company - MarketScreener

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company MarketScreener

Ashurst advises APONTIS PHARMA on investment agreement with Zentiva - Ashurst

Ashurst advises APONTIS PHARMA on investment agreement with Zentiva Ashurst

How Apontis Pharma AG (APPH) stock reacts to monetary easing - Weekly Trade Review & Capital Efficient Trading Techniques - newser.com

How Apontis Pharma AG (APPH) stock reacts to monetary easing - Weekly Trade Review & Capital Efficient Trading Techniques newser.com

Kirkland, Freshfields Advise on Private Equity House GTCR’s $4.8B Zentiva Pharma Acquisition - Law.com

Kirkland, Freshfields Advise on Private Equity House GTCR’s $4.8B Zentiva Pharma Acquisition Law.com

Ashurst advises APONTIS PHARMA on Squeeze-out - Ashurst

Ashurst advises APONTIS PHARMA on Squeeze-out Ashurst

Polypill for blood pressure lowering may improve adherence and reduce mortality - Healio

Polypill for blood pressure lowering may improve adherence and reduce mortality Healio

Top Apontis Pharma Deutschland Gmbh & Co. Kg Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant